Maynard Um
-
-
-
-
-
-
-
Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval
-
-
-
-
-
-
-
Citius Oncology (CTOR) Files $200M Mixed Shelf
-
-
-
-
-
-
-
Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
-
-
471,976 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


